RNGE · Range Impact, Inc. · Insider Trading
The latest filing no longer states the doubt (first flagged May 15, 2026).
View the 10-Q filed Aug 12, 2026Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-15 | Celeste Richard F |
Director |
Convert↑
|
Common Stock
|
250,000 |
| 2026-06-15 | Celeste Richard F |
Director |
Convert↓
|
Option under Stock Incentive Plan
|
250,000 |
| 2025-12-31 | FEIGHAN EDWARD F |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On December 31, 2025, the Reporting Person was granted options to purchase 250,000 shares of common stock at an exercise price of $0.15. This option vested immediately. |
Stock Option (Right to Buy)
|
250,000 |
| 2025-12-31 | Missal Patricia Ann |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On December 31. 2025, the Reporting Person was granted options to purchase 150,000 shares of common stock at an exercise price of $0.15. This option vested immediately. |
Stock Option (Right to Buy)
|
150,000 |
| 2025-12-31 | Cavanaugh Michael R. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On December 31, 2025, the Reporting Person was granted options to purchase 250,000 shares of common stock at an exercise price of $0.15. This option vested immediately. |
Stock Option (Right to Buy)
|
250,000 |
| 2025-12-31 | Celeste Richard F |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On December 31. 2025, the Reporting Person was granted options to purchase 250,000 shares of common stock at an exercise price of $0.15. This option vested immediately. |
Stock Option (Right to Buy)
|
250,000 |
| 2025-09-23 | FEIGHAN EDWARD F |
Director |
Buy↑
|
Common Stock
|
666,667 |
| 2025-09-23 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
2,333,333 |
| 2025-09-23 | Cavanaugh Michael R. |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
666,667 |
| 2025-04-07 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
3,000 |
| 2025-04-07 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
110,000 |
| 2025-04-03 | Cavanaugh Michael R. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On April 3, 2025, the Reporting Person was granted options to purchase 250,000 shares of common stock at an exercise price of $0.148. This option vested immediately. |
Stock Option (Right to Buy)
|
250,000 |
| 2025-04-03 | Celeste Richard F |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On April 3, 2025, the Reporting Person was granted options to purchase 250,000 shares of common stock at an exercise price of $0.148. This option vested immediately. |
Stock Option (Right to Buy)
|
250,000 |
| 2025-04-03 | FEIGHAN EDWARD F |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On April 3, 2025, the Reporting Person was granted options to purchase 250,000 shares of common stock at an exercise price of $0.148. This option vested immediately. |
Stock Option (Right to Buy)
|
250,000 |
| 2025-02-18 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
5,000 |
| 2025-02-06 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
5,000 |
| 2025-01-28 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
5,000 |
| 2025-01-21 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
3,333,333 |
| 2023-12-21 | FEIGHAN EDWARD F |
Director |
Buy↑
|
Common Stock
|
666,667 |
| 2023-12-21 | FEIGHAN EDWARD F |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On December 21, 2023, the Reporting Person was granted options to purchase 250,000 shares of common stock at an exercise price of $0.212. This option vested immediately. |
Stock Option (Right to Buy)
|
250,000 |
| 2023-12-21 | Cavanaugh Michael R. |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
1,000,000 |
| 2023-12-21 | Cavanaugh Michael R. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On December 21, 2023, the Reporting Person was granted options to purchase 1,000,000 shares of common stock at an exercise price of $0.212. This option vested immediately. |
Stock Option (Right to Buy)
|
1,000,000 |
| 2023-12-21 | Celeste Richard F |
Director |
Award↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
On December 21, 2023, the Reporting Person was granted options to purchase 250,000 shares of common stock at an exercise price of $0.212. This option vested immediately. |
Stock Option (Right to Buy)
|
250,000 |
| 2023-12-18 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
1,000 |
| 2023-12-18 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
2,100 |
| 2023-12-14 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
16,225 |
| 2023-12-13 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
1,400 |
| 2023-12-12 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
49,579 |
| 2023-12-12 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
60,422 |
| 2023-10-30 | LoConti Joseph E. |
10% Owner |
Other↓
Filing footnotes — Warrant (Direct)
Warrants to purchase 6,666,667 shares of Issuer's common stock were exchanged for 666,667 shares of Issuer's common stock in a private transaction entered into between the Reporting Person and Issuer. |
Warrant
|
6,666,667 |
| 2023-10-30 | Indemnity National Insurance Co |
10% Owner |
Buy↑
Filing footnotes — Common Stock, par value $0.001 per share (Direct)
The 1,333,333 shares of Common Stock were exchanged for 13,333,333 Warrants held by Reporting Person pursuant to a Warrant Exchange Agreement This total reflects the consolidated transaction, which includes the disposition of Warrants (detailed below) and acquisition of Common Stock |
Common Stock, par value $0.001 per share
|
1,333,333 |
| 2023-10-30 | Indemnity National Insurance Co |
10% Owner |
Sell↓
Filing footnotes — Warrants (Direct)
The 13,333,333 Warrants held by Reporting Person were exchanged for 1,333,333 shares of Common Stock pursuant to a Warrant Exchange Agreement |
Warrants
|
13,333,333 |
| 2023-10-30 | LoConti Joseph E. |
10% Owner |
Buy↑
Filing footnotes — Common Stock, par value $0.001 per share (Indirect)
Warrants to purchase 6,666,667 shares of Issuer's common stock were exchanged for 666,667 shares of Issuer's common stock in a private transaction entered into between the Reporting Person and Issuer. |
Common Stock, par value $0.001 per share
(I)
|
666,667 |
| 2023-08-24 | Indemnity National Insurance Co |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
|
6,666,667 |
| 2023-04-28 | FEIGHAN EDWARD F |
Director |
Buy↑
|
Common Stock
|
30,000 |
| 2023-04-26 | FEIGHAN EDWARD F |
Director |
Buy↑
|
Common Stock
|
2,000 |
| 2023-04-25 | FEIGHAN EDWARD F |
Director |
Buy↑
|
Common Stock
|
2,000 |
| 2023-04-21 | FEIGHAN EDWARD F |
Director |
Buy↑
|
Common Stock
|
5,000 |
| 2023-04-21 | FEIGHAN EDWARD F |
Director |
Buy↑
|
Common Stock
|
10,000 |
| 2023-04-19 | FEIGHAN EDWARD F |
Director |
Buy↑
|
Common Stock
|
1,000 |
| 2023-04-11 | FEIGHAN EDWARD F |
Director |
Buy↑
|
Common Stock Purchase Warrant (right to buy)
|
333,333 |
| 2023-04-11 | FEIGHAN EDWARD F |
Director |
Buy↑
|
Common Stock
|
333,333 |
| 2022-11-30 | MCKILLIGAN RICHARD |
Chief Financial Officer |
Award↑
|
Stock Option (Right to Buy)
|
250,000 |
| 2022-11-30 | Celeste Richard F |
Director |
Award↑
|
Stock Option (Right to Buy)
|
250,000 |
| 2022-11-30 | Cavanaugh Michael R. |
Director, Chief Executive Officer |
Award↑
|
Stock Option (Right to Buy)
|
750,000 |
| 2022-11-30 | Zipp Brandon Joel |
Chief Science Officer |
Award↑
|
Stock Option (Right to Buy)
|
250,000 |
| 2022-11-30 | FEIGHAN EDWARD F |
Director |
Award↑
|
Stock Option (Right to Buy)
|
250,000 |
| 2022-05-10 | LoConti Joseph E. |
10% Owner |
Buy↑
|
Common Stock, par value $0.001 per share
(I)
|
6,666,667 |
| 2022-05-10 | LoConti Joseph E. |
10% Owner |
Award↑
Filing footnotes — Warrant (Indirect)
Warrant acquired in connection with purchase of restricted shares of Issuer's common stock reflected in table I of this Form 4. |
Warrant
(I)
|
6,666,667 |
| 2021-12-10 | Zipp Brandon Joel |
Chief Science Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On December 10, 2021, the issuer canceled this option, pursuant to the issuer's option exchange program, the options listed above. In exchange, the Reporting Person received a replacement option to purchase 127,487 shares at an exercise price of $0.277. This replacement option vested immediately. |
Stock Option (Right to Buy)
|
127,487 |